Variant report
Variant | esv3358599 |
---|---|
Chromosome Location | chr2:211991114-211991598 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140335610 | chr2:211991121-211991122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs371618513 | chr2:211991123-211991124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376679681 | chr2:211991126-211991127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560746995 | chr2:211991150-211991151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529867191 | chr2:211991151-211991152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540121277 | chr2:211991195-211991196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6723493 | chr2:211991229-211991230 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs150213916 | chr2:211991234-211991235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572928919 | chr2:211991240-211991241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138778389 | chr2:211991262-211991263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs148959310 | chr2:211991314-211991315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183053842 | chr2:211991367-211991368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs78453869 | chr2:211991395-211991396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs35218600 | chr2:211991437-211991438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567841546 | chr2:211991438-211991439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536805091 | chr2:211991444-211991445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187388023 | chr2:211991489-211991490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs13400493 | chr2:211991518-211991519 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs7574280 | chr2:211991553-211991554 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs191918519 | chr2:211991563-211991564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538561570 | chr2:211991566-211991567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 21346763 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 17661082 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:211989000-211991600 | Enhancers | Brain Germinal Matrix | brain |
2 | chr2:211991000-211991800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr2:211991000-211991800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr2:211991000-211991800 | Enhancers | Fetal Intestine Small | intestine |